Literature DB >> 21345805

VEGF/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart.

Jun-Ming Tang1, Jia-Ning Wang, Lei Zhang, Fei Zheng, Jian-Ye Yang, Xia Kong, Lin-Yun Guo, Long Chen, Yong-Zhang Huang, Yu Wan, Shi-You Chen.   

Abstract

AIMS: The objective of this study was to investigate whether vascular endothelial growth factor (VEGF) secreted by mesenchymal stem cells (MSC) improves myocardial survival and the engraftment of implanted MSC in infarcted hearts and promotes recruitment of stem cells through paracrine release of myocardial stromal cell-derived factor-1α (SDF-1α). METHODS AND
RESULTS: VEGF-expressing MSC ((VEGF)MSC)-conditioned medium enhanced SDF-1α expression in heart slices and H9C2 cardiomyoblast cells via VEGF and the vascular endothelial growth factor receptor (VEGFR). The (VEGF)MSC-conditioned medium markedly promoted cardiac stem cell (CSC) migration at least in part via the SDF-1α/CXCR4 pathway and involved binding to VEGFR-1 and VEGFR-3. In vivo, (VEGF)MSC-stimulated SDF-1α expression in infarcted hearts resulted in massive mobilization and homing of bone marrow stem cells and CSC. Moreover, VEGF-induced SDF-1α guided the exogenously introduced CSC in the atrioventricular groove to migrate to the infarcted area, leading to a reduction in infarct size. Functional studies showed that (VEGF)MSC transplantation stimulated extensive angiomyogenesis in infarcted hearts as indicated by the expression of cardiac troponin T, CD31, and von Willebrand factor and improved the left ventricular performance, whereas blockade of SDF-1α or its receptor by RNAi or antagonist significantly diminished the beneficial effects of (VEGF)MSC.
CONCLUSION: Exogenously expressed VEGF promotes myocardial repair at least in part through SDF-1α/CXCR4-mediated recruitment of CSC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21345805      PMCID: PMC3139446          DOI: 10.1093/cvr/cvr053

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  37 in total

1.  Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells.

Authors:  Massimiliano Gnecchi; Huamei He; Olin D Liang; Luis G Melo; Fulvio Morello; Hui Mu; Nicolas Noiseux; Lunan Zhang; Richard E Pratt; Joanne S Ingwall; Victor J Dzau
Journal:  Nat Med       Date:  2005-04       Impact factor: 53.440

Review 2.  An SDF-1 trap for myeloid cells stimulates angiogenesis.

Authors:  Carmen Ruiz de Almodovar; Aernout Luttun; Peter Carmeliet
Journal:  Cell       Date:  2006-01-13       Impact factor: 41.582

3.  Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction.

Authors:  Ryo Matsumoto; Takashi Omura; Minoru Yoshiyama; Tetsuya Hayashi; Sakiko Inamoto; Ki-Ryang Koh; Kensuke Ohta; Yasukatsu Izumi; Yasuhiro Nakamura; Kaname Akioka; Yasushi Kitaura; Kazuhide Takeuchi; Junichi Yoshikawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-04-14       Impact factor: 8.311

4.  The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model.

Authors:  Sang Yup Lim; Yong Sook Kim; Youngkeun Ahn; Myung Ho Jeong; Moon Hwa Hong; Soo Yeon Joo; Kwang Il Nam; Jeong Gwan Cho; Peter M Kang; Jong Chun Park
Journal:  Cardiovasc Res       Date:  2006-03-06       Impact factor: 10.787

5.  Mesenchymal stem cells are superior to angiogenic growth factor genes for improving myocardial performance in the mouse model of acute myocardial infarction.

Authors:  Kou-Gi Shyu; Bao-Wei Wang; Huei-Fong Hung; Chih-Chuan Chang; Daniel Tzu-Bi Shih
Journal:  J Biomed Sci       Date:  2005-11-09       Impact factor: 8.410

6.  Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells.

Authors:  Carmen Urbich; Alexandra Aicher; Christopher Heeschen; Elisabeth Dernbach; Wolf K Hofmann; Andreas M Zeiher; Stefanie Dimmeler
Journal:  J Mol Cell Cardiol       Date:  2005-09-29       Impact factor: 5.000

7.  Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling.

Authors:  Ryota Uemura; Meifeng Xu; Nauman Ahmad; Muhammad Ashraf
Journal:  Circ Res       Date:  2006-05-11       Impact factor: 17.367

Review 8.  How do stem cells find their way home?

Authors:  Tsvee Lapidot; Ayelet Dar; Orit Kollet
Journal:  Blood       Date:  2005-05-12       Impact factor: 22.113

9.  Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model.

Authors:  Guilherme V Silva; Silvio Litovsky; Joao A R Assad; Andre L S Sousa; Bradley J Martin; Deborah Vela; Stephanie C Coulter; Jing Lin; Judy Ober; William K Vaughn; Rodrigo V C Branco; Edie M Oliveira; Rumin He; Yong-Jian Geng; James T Willerson; Emerson C Perin
Journal:  Circulation       Date:  2005-01-10       Impact factor: 29.690

10.  Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement.

Authors:  Massimiliano Gnecchi; Huamei He; Nicolas Noiseux; Olin D Liang; Lunan Zhang; Fulvio Morello; Hui Mu; Luis G Melo; Richard E Pratt; Joanne S Ingwall; Victor J Dzau
Journal:  FASEB J       Date:  2006-04       Impact factor: 5.191

View more
  103 in total

1.  CXCR4 gene transfer prevents pressure overload induced heart failure.

Authors:  Thomas J Larocca; Dongtak Jeong; Erik Kohlbrenner; Ahyoung Lee; Jiqiu Chen; Roger J Hajjar; Sima T Tarzami
Journal:  J Mol Cell Cardiol       Date:  2012-06-03       Impact factor: 5.000

Review 2.  Cardiac cell therapy: boosting mesenchymal stem cells effects.

Authors:  E Samper; A Diez-Juan; J A Montero; P Sepúlveda
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

3.  Intramuscular VEGF activates an SDF1-dependent progenitor cell cascade and an SDF1-independent muscle paracrine cascade for cardiac repair.

Authors:  David Zisa; Arsalan Shabbir; Michalis Mastri; Tyler Taylor; Ilija Aleksic; Mary McDaniel; Gen Suzuki; Techung Lee
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-30       Impact factor: 4.733

4.  Enhancement of mesenchymal stem cell angiogenic capacity and stemness by a biomimetic hydrogel scaffold.

Authors:  Kristine C Rustad; Victor W Wong; Michael Sorkin; Jason P Glotzbach; Melanie R Major; Jayakumar Rajadas; Michael T Longaker; Geoffrey C Gurtner
Journal:  Biomaterials       Date:  2011-10-02       Impact factor: 12.479

5.  VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.

Authors:  D Zhao; C Pan; J Sun; C Gilbert; K Drews-Elger; D J Azzam; M Picon-Ruiz; M Kim; W Ullmer; D El-Ashry; C J Creighton; J M Slingerland
Journal:  Oncogene       Date:  2014-08-25       Impact factor: 9.867

6.  Sequential delivery of angiogenic growth factors improves revascularization and heart function after myocardial infarction.

Authors:  Hassan K Awada; Noah R Johnson; Yadong Wang
Journal:  J Control Release       Date:  2015-03-31       Impact factor: 9.776

7.  Manganese superoxide dismutase inhibits neointima formation through attenuation of migration and proliferation of vascular smooth muscle cells.

Authors:  Jia-Ning Wang; Ning Shi; Shi-You Chen
Journal:  Free Radic Biol Med       Date:  2011-10-24       Impact factor: 7.376

8.  HSPA12B and repairing the heart: beauty in simplicity.

Authors:  Fouad A Zouein; Mazen Kurdi; George W Booz
Journal:  Cardiovasc Res       Date:  2013-07-18       Impact factor: 10.787

9.  SDF-1 enhances wound healing of critical-sized calvarial defects beyond self-repair capacity.

Authors:  Qiming Jin; William V Giannobile
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

10.  Irx4 Marks a Multipotent, Ventricular-Specific Progenitor Cell.

Authors:  Daryl O Nelson; Pratik A Lalit; Mitch Biermann; Yogananda S Markandeya; Deborah L Capes; Luke Addesso; Gina Patel; Tianxiao Han; Manorama C John; Patricia A Powers; Karen M Downs; Timothy J Kamp; Gary E Lyons
Journal:  Stem Cells       Date:  2016-09-13       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.